KALA SEC Filings: 8-K, 10-Q, S-3 & 424B – KALA BIO

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

NEWKALA BIO Provides CEO Update and Reports Preliminary Third Quarter 2026 Financial Results

Nov 9, 2026

8-K

KALA BIO, INC. Announces Voting Results from Annual Meeting of Stockholders

Nov 3, 2026

8-K

KALA BIO Enters Exclusive Distribution and Reseller Agreement with Virotek for Ophthalmology Genetic Testing Program

Sep 10, 2026

8-K

KALA BIO Sets Date for 2026 Annual Meeting of Stockholders and Establishes Stockholder Proposal Deadlines

Sep 9, 2026

8-K

KALA BIO, Inc. Receives Nasdaq Delisting Notice Regarding Minimum Bid Price Requirement

Aug 28, 2026

8-K

KALA BIO, Inc. Files Prospectus Supplement for Securities Offering

Jul 22, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

[No Baby Shelf]* July 2026 ATM | Offering amount: $250,000,000 | Bank: H.C. Wainwright & Co.

Jul 22, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 241,435,910

Feb 17, 2026

424B5

January 2026 ATM | Offering amount: $15,000,000

Jan 8, 2026

424B5

REGISTERED OFFERING

Dec 5, 2025

424B5

March 2025 ATM

Mar 31, 2025

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Feb 4, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-3/A

June 2026 SHELF

Jun 12, 2026

S-3

May 2026 SHELF

May 7, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Mar 17, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Feb 12, 2026

S-3

SHARE RESALE REGISTRATION

Feb 9, 2026

S-3

Form S-3 - Registration statement under Securities Act of 1933

Jan 24, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

Sep 24, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Sep 11, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jan 26, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jan 6, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Dec 30, 2025

PRER14A

Form PRER14A - Preliminary Proxy Soliciting materials

Dec 19, 2025

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 26, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 18, 2026

CORRESP

Form CORRESP - Correspondence

Feb 13, 2026

LETTER

Form UPLOAD - SEC-generated letter

Feb 13, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 5, 2025

CORRESP

Form CORRESP - Correspondence

Jan 31, 2025

KALA BIO, Inc. KALA · SEC Filings